Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans

References

• Casadevall A, Perfect JR. Cryptococcus neoformans. Washington, DC: ASM Press, 1998.
   Google Scholar
• Murphy JW. Cell-mediated immunity and medically related fungi. In: Cunningham MW, Fujinami RS (eds). Effects of Microbes on the Immune System. Philadelphia: Lippincott Williams and Wilkins, 2000: 593–621.
   Google Scholar
• Aguirre K, Havell EA, Gibson GW, Johnson LL. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect Immun 1995; 63: 1725–1731.
   PubMed Web of Science ®Google Scholar
• Hill JO, Aguirre KM. CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neofor-mans. J Immunol 1994; 152: 2344–2350.
   PubMed Web of Science ®Google Scholar
• Lutz JE, Clemons KY, Stevens DA. Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis. J Ant imicrob Chemother 2000; 46: 437–442.
   Google Scholar
• Buchanan KL, Doyle HA. Requirement for CD4+ T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice. Infect Immun 2000; 68: 456–462.
   PubMed Web of Science ®Google Scholar
• Hoag KA, Street NE, Huffnagle GB, Lipscomb ME Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J Respir Cell Mol Biol 1995; 13: 487–495.
   PubMed Web of Science ®Google Scholar
• Hoag KA, Lipscomb MF, Izzo AA, Street NE. IL-12 and IFN-gamma are required for initiating the protective Thl response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol 1997; 17: 733–739.
   Google Scholar
• Huffnagle GB, Lipscomb MF, Lovchik JA, Hoag KA, Street NE. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J Leukoc Biol 1994; 55: 35–42.
   Google Scholar
• Huffnagle GB, Traynor TR, McDonald RA, et al. Leukocyte recruitment during pulmonary Cryptococcus neoformans infec-tion. Immunopharm 2000; 48: 231–236.
   Google Scholar
• Huffnagle GB, Strieter RM, McNeil LK, et al. Macrophage inflammatory protein-lalpha (MIP-lalpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Crypto-coccus neoformans infection. J Immunol 1997; 159: 318–327.
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, Strieter RM, Standiford TJ, et al. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J Immunol 1995; 155: 4790–4797.
   PubMedGoogle Scholar
• Doyle HA, Murphy JW. MIP-1 alpha contributes to the antic-ryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J Leukoc Biol 1997; 61: 147–155.
   PubMedGoogle Scholar
• Murphy JW, Cozad GC. Immunological unresponsiveness in-duced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun 1972; 5: 896–901.
   PubMed Web of Science ®Google Scholar
• Buchanan KL, Murphy JW. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect Immun 1993; 61: 2854–2865.
   PubMed Web of Science ®Google Scholar
• Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for the determination of sugars and related substances. Anal Chem 1956; 28: 350–356.
   Google Scholar
• Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SR Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 1991; 266: 10331–10336.
   PubMed Web of Science ®Google Scholar
• Granowitz EV, Clark BD, Mancilla J, Dinarello CA. Interleukin-1 receptor antagonist competitively inhibits the binding of inter-leukin-1 to the type II interleukin-1 receptor. J Biol Chem 1991; 266: 14147–14150.
   PubMed Web of Science ®Google Scholar
• Szelenyi J. Cytokines and the central nervous system. Brain Res Bull 2001; 54: 329–338.
   PubMed Web of Science ®Google Scholar
• Blasi E, Mazzolla R, Barluzzi R, Mosci P, Bistoni F. Antic-ryptococcal resistance in the mouse brain: beneficial effects of local administration of heat-inactivated yeast cells. Infect Immun 1994; 62: 3189–3196.
   Google Scholar
• Buchanan KL, Murphy JW. Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology 1997; 90: 189–197.
   PubMed Web of Science ®Google Scholar
• Kawakami K, Kinjo Y, Uezu K, et al. Monocyte chemoattractant protein- 1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Thl response and host defense in cryptococcal infection. J Immunol 2001; 167: 6525–6532.
   PubMed Web of Science ®Google Scholar
• Olszewski MA, Huffnagle GB, McDonald RA, et al. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J Immunol 2000; 165: 6429–6436.
   PubMed Web of Science ®Google Scholar
• Huffnagle GB, McNeil LK, McDonald RA, et al. Cutting edge: Role of C-C chemokine receptor 5 in organ-specific and innate immunity to Cryptococcus neoformans. J Immunol 1999; 163: 4642–4646.
   PubMed Web of Science ®Google Scholar
• Siveke JT, Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol 1998; 160: 550–554.
   PubMedGoogle Scholar
• Qin S, Rottman JB, Myers P, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101: 746–754.
   PubMed Web of Science ®Google Scholar
• Khan IA, MacLean JA, Lee FS, et al. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 2000; 12: 483–494.
   PubMed Web of Science ®Google Scholar
• Sorensen TL, Sellebjerg F, Jensen CV, Strieter RM, Ransohoff RM. Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis. Eur J Neurol 2001; 8: 665 —672.
   Google Scholar
• Ransohoff RM, Wei T, Pavelko KD, et al. Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4 + and CD8+ T cells and viral persistence. J Virol 2002; 76: 2217–2224.
   Web of Science ®Google Scholar
• Liu MT, Keirstead HS, Lane TE. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol 2001; 167: 4091–4097.
   Google Scholar
• Fife BT, Kennedy KJ, Paniagua MC, et al. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4 T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 2001; 166: 7617–7624.
   PubMed Web of Science ®Google Scholar
• Kutsch 0, Oh J, Nath A, Benveniste EN. Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol 2000; 74: 9214–9221.
   Google Scholar
• Asensio VC, Maier J, Milner R, et al. Interferon-independent, human immunodeficiency virus type 1 gp120- mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol 2001; 75: 7067–7077.
   Google Scholar
• Seebach J, Bartholdi D, Frei K, et al. Experimental Listeria meningoencephalitis. Macrophage inflammatory protein-1 alpha and -2 are produced intrathecally and mediate chemotactic activity in cerebrospinal fluid of infected mice. J Immunol 1995; 155: 4367–4375.
   Google Scholar
• Chaka W, Verheul AF, Vaishnav VV, et al. Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human man-nose binding protein. J Immunol 1997; 159: 2979–2985.
   PubMed Web of Science ®Google Scholar
• Delfino D, Cianci L, Lupis E, et al. Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. Infect Immun 1997; 65: 2454–2456.
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A, Retini C, Pietrella D, et al. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect Immun 1995; 63: 2919–2923.
   PubMed Web of Science ®Google Scholar
• Blasi E, Barluzzi R, Mazzolla R, et al. Biomolecular events involved in anticryptococcal resistance in the brain. Infect Immun 1995; 63: 1218–1222.
   PubMed Web of Science ®Google Scholar
• Lee SC, Dickson DW, Brosnan CF, Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 1994; 180: 365–369.
   PubMed Web of Science ®Google Scholar
• Martin D, Near SL. Protective effect of the interleukin-1 receptor antagonist (IL- lra) on experimental allergic encephalomyelitis in rats. J Neuroimmunol 1995; 61: 241–245.
   PubMed Web of Science ®Google Scholar
• Badovinac V, Mostarica-Stojkovic M, Dinarello CA, Stosic-Grujicic S. Interleukin-1 receptor antagonist suppresses experi-mental autoimmune encephalomyelitis (EAE) in rats by influen-cing the activation and proliferation of encephalitogenic cells. J Neuroimmunol 1998; 85: 87–95.
   Google Scholar
• de Jong BA, Huizinga TW, Bollen EL, et al. Production of IL-lbeta and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis. J Neuroimmunol 2002; 126: 172–179.
   PubMedGoogle Scholar